Regulation & Compliance

Thermon Group's $2.2 billion sale to CECO Environmental faces legal scrutiny, leaving shareholders to question if the offer is fair amid record profits.

A new report on 1,800+ patients reveals a model for obesity care that preserves muscle, sustains weight loss, and may solve the GLP-1 cost crisis.

Leading crypto ATM operator Bitcoin Depot now requires ID for every transaction, a move aimed at fighting fraud but raising questions about user access.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

A new voter tool uses AI to score Texas primary candidates on collaboration over conflict, aiming to reshape how voters choose their representatives.

The partnership moves beyond compliance, integrating deep binary analysis with lifecycle management to provide continuous software risk intelligence for critical industries.

As Autolus heads to key investor conferences, its strong AUCATZYL® sales and deep pipeline face scrutiny against mounting losses and a curious PR misstep.

A new report shows patients are rejecting 'overdone' looks for subtle, strategic care, driven by Ozempic, menopause, and a desire for authenticity.

A new partnership aims to replace paper with blockchain, promising to slash fraud, cut costs, and revolutionize how global commerce operates.

A new 'technology-only' law firm has been approved in the UK. Can its deterministic AI make legal help more affordable and consistent for everyone?

Fintech unicorn Clear Street pulls its much-anticipated IPO, a move that highlights a tough market forcing many tech firms to reconsider public debuts.

With overwhelming bondholder support, the media giant gains financial flexibility for shareholder returns while tightening protections for its creditors.

A new partnership brings an FDA-designated breakthrough device to more patients, fueled by a key Medicare payment that could reshape the trauma market.

The fusion energy pioneer plans to go public via a SPAC merger, seeking capital to prove its unique technology and win the race for limitless clean power.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

A new partnership brings hyper-local weather AI to snow removal, promising fewer slip-and-falls, smarter salt use, and ironclad liability protection.

With a new CEO and a key investor conference ahead, Metagenomi bets on its unique metagenomics platform and a hemophilia drug to navigate a tough market.

The California bank says it's protected by strong collateral, but the move highlights growing risks in the commercial real estate lending sector.

As cannabis use grows, new data reveals a deadly toll on Texas roads, with 120 deaths annually, sparking calls for action and a complex policy debate.

Relm is tackling the tech talent gap with new scholarships at the University of Miami and in Bermuda, creating pathways into emerging risk sectors.